The Company's valve is used to treat heart valve failure caused by the natural aging process, rheumatic heart disease, prosthetic valve failure and congenital defects. This unique open pivot has been designed to eliminate the cavity associated with the pivot of other bileaflet valves and to improve the ability of the blood to flow through the valve without forming clots. The Company sells the ATS Valve in international markets and sponsors clinical trials.
Revenues reflect a higher average selling price for the Valve.
Loss reflects an increase in sales and marketing costs. VP of Regulatory Affairs and Sec. All Rights Reserved. Privacy Policy - Terms of Service Company information Copyright Market Guide . Data and information is provided for informational purposes only, and is not intended for trading purposes.